HAE
$51.92
Haemonetics
($3.39)
(6.13%)
Earnings Details
2nd Quarter September 2021
Tuesday, November 9, 2021 6:00:00 AM
Tweet Share Watch
Summary

Haemonetics Misses

Haemonetics (HAE) reported 2nd Quarter September 2021 earnings of $0.60 per share on revenue of $239.9 million. The consensus earnings estimate was $0.63 per share on revenue of $240.0 million. The Earnings Whisper number was $0.66 per share. Revenue grew 14.5% on a year-over-year basis.

The company said it expects fiscal 2022 earnings of $2.40 to $2.65 per share on revenue of $931.4 million to $957.5 million. The company's previous guidance was earnings of $2.60 to $3.00 per share on revenue of $983.6 million to $1.027 billion and the current consensus earnings estimate is $2.77 per share on revenue of $1.01 billion for the year ending March 31, 2022.

Haemonetics Corp is a healthcare company that provides blood management solutions to its customers. It serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors, and hospitals.

Results
Reported Earnings
$0.60
Earnings Whisper
$0.66
Consensus Estimate
$0.63
Reported Revenue
$239.9 Mil
Revenue Estimate
$240.0 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

BOSTON, Nov. 9, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal 2022, which ended October 2, 2021, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EST on November 9, 2021. The conference call and webcast can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
  • Conference ID required for access: 3529538
  • A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/apntfy73

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.  

Direct link to 2Q FY22 Earnings Release:
https://haemonetics.gcs-web.com/static-files/97dd4f39-ebc7-4f1c-9058-dc2e6305d3c3 

Direct link to 2Q FY22 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/1f8f1f7d-24a0-46a4-8c34-20846dcc0a28

A replay of the conference call and webcast will be available for one year beginning on November 9, 2021 at 11:00 a.m. EST using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact

Media Contact

Olga Guyette, Director-Investor Relations

Josh Gitelson, Director-Global Communications

(781) 356-9763

(781) 356-9776

olga.guyette@haemonetics.com

josh.gitelson@haemonetics.com  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301419233.html

SOURCE Haemonetics Corporation